Prof Alexandre Mebazaa is a Professor of Medicine at Paris Cité University, Paris, FR.

He is also Director of INSERM Unit 942 Mascot and Chair of Department of Anesthesia & Critical Care, Paris, FR.

Prof Mebazaa leads a large research group on biomarkers and biotherapies in critical conditions, named MASCOT granted by the Université de Paris Cité and Inserm. He is part of the task force that wrote the 2021 ESC / HFA Guidelines of Heart Failure and the 2023 addendum.

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…